Material Agreements

ALLIANT ENERGY CORP entered into Credit Agreement with U.S. Bank National Association valued at $400 million (effective 2026-03-02).

“On March 2, 2026, Alliant Energy Corporation (the “Company”) entered into a term loan credit agreement (the “Credit Agreement”) among the Company, U.S. Bank National Association, as Administrative Agent, and the several lenders party thereto. The Credit Agreement provides for a $400 million term loan facility.”

Emmaus Life Sciences, Inc. entered into Exclusive Supply Agreement with NeoImmuneTech, Inc. (NIT) (effective 2026-03-02).

“n March 2, 2026, Emmaus and NIT entered into the Exclusive Supply Agreement contemplated by the License Agreement. Subject to the occurrence”

Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).

“On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).”

SSR MINING INC. entered into MoU with Cengiz Holding A.S. valued at $1.5 billion (effective 2026-03-03).

“On March 3, 2026, SSR Mining Inc., a British Columbia corporation (the “Company”), entered into a binding memorandum of understanding (the “MoU”) with Cengiz Holding A.S. (“Cengiz Holding”) to sell its 80% ownership interest in the Çöpler mine and related properties in Türkiye (collectively, “Çöpler”) for $1.5 billion (the “Purchase Price”) in cash (the “Transaction”).”

Azenta, Inc. entered into Share Purchase Agreement with UK Biocentre Limited valued at GBP 20.5 million (effective 2026-03-04).

“On March 4, 2026, Azenta UK Ltd., a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Share Purchase Agreement (“Agreement”) under which Azenta UK Ltd. acquired all the issued and outstanding share capital of UK Biocentre Limited (“UK Biocentre”), a provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom.”

SMITH MICRO SOFTWARE, INC. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $4.9 million (effective 2026-03-04).

“On March 4, 2026, Smith Micro Software, Inc. (the “ Company ”, “ we ,” “ us ,” “ our ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain accredited investors (the “ Buyers ”) and, pursuant to the Purchase Agreement, agreed to sell to the Buyers a new series of secured convertible notes (the “ Convertible Notes ”) with an aggregate original principal amount of approximately $4.9 million”

TREX CO INC entered into Forward Share Repurchase Transaction Confirmation with Wells Fargo Bank, National Association valued at $100,000,000 (effective 2026-02-26).

“On February 26, 2026, Trex Company, Inc. (the “Company”) entered into a Forward Share Repurchase Transaction Confirmation (the “Confirmation”) with Wells Fargo Bank, National Association (“Wells Fargo”).”

PROGRESS ENERGY INC entered into Amended and Restated Limited Liability Company Operating Agreement of Florida Progress with Investor (effective 2026-03-03).

“On March 3, 2026, in connection with the First Closing, Investor, Florida Progress and Progress Energy entered into an Amended and Restated Limited Liability Company Operating Agreement of Florida Progress (the “LLC Agreement”).”

CHINA PHARMA HOLDINGS, INC. entered into Technology Transfer Agreement with Xiaoyan Zhang valued at $6.93 million (effective 2026-02-26).

“On February 26, 2026 (the “Signing Date”), Hainan Helpson Medical & Biotechnology Co., Ltd (“ Helpson ”), a wholly owned subsidiary of China Pharma Holdings, Inc. (the “ Company ”), entered into a Technology Transfer Agreement (the “ Agreement ”) with Xiaoyan Zhang (the “ Transferor ”). The Transferor owns an invention patent of an Prinsepia Utilis Esterol Sublingual Tablets and Method for Its Preparation (the “ Invention Patent ”). Pursuant to the Agreement, the Transferor will transfer the ownership of the Invention Patent to Helpson. The Transferor or its designated third party shall provide relevant technical services, which include but are not limited to product research and development, writing of registration materials, registration application and other technical services. The transfer price as contemplated by the Agreement is $6.93 million, which will be paid in the form of common stock of the Company, par value $0.001 per share, at $0.55 per share.”

TXNM ENERGY INC entered into Distribution Agreement with BofA Securities, Inc., MUFG Securities Americas Inc. and Scotia Capital (USA) Inc. (each, a "Sales Agent" and collectively, the "Sales Agents") and Bank of America, N.A., MUFG Securities EMEA plc and The Bank of Nova Scotia, as Forward Purchasers valued at $125 million (effective 2026-03-03).

“On March 3, 2026, TXNM Energy, Inc. (the “Company”) entered into a Distribution Agreement (the “Distribution Agreement”) with BofA Securities, Inc., MUFG Securities Americas Inc. and Scotia Capital (USA) Inc. (each, a “Sales Agent” and collectively, the “Sales Agents”) and Bank of America, N.A., MUFG Securities EMEA plc and The Bank of Nova Scotia, as Forward Purchasers (each, a “Forward Purchaser” and collectively, the “Forward Purchasers”), pursuant to which the Company may sell, from time to time, up to an aggregate sales price of $125 million of its common stock, no par value (the “Shares”), through the Sales Agents.”

Global Arena Holding, Inc. entered into 2026 Easterly APA with GES Acquisition Corp., Easterly CV VI LLC (effective 2026-02-26).

“On February 26, 2026, following termination of the 2025 Easterly APA (as hereinafter defined), Global Arena Holding, Inc. (the “Company”) entered into that certain Asset Purchase Agreement (the “2026 Easterly APA”) with Global Election Services, Inc. (“GE Services” and together with the Company, the “Sellers”), GES Acquisition Corp. (“GES Acquisition”), and Easterly CV VI LLC (“Easterly”).”

Star Equity Holdings, Inc. entered into ADT Wyoming Lease Agreement with Pasture Drive Holdings, LLC (effective 2026-02-27).

“Simultaneous with the consummation of the ADT Wyoming Sale and Leaseback Transaction, the Company entered into a commercial single-tenant triple net lease, guaranteed by the Company (the “ADT Wyoming Lease Agreement”) with ADT Wyoming Buyer, pursuant to which ADT, a wholly-owned subsidiary of the Company, leased back from ADT Wyoming Buyer the ADT Wyoming Property for a term commencing upon the execution of the ADT Wyoming Lease Agreement and ending on the 20th anniversary thereof, unless earlier terminated or extended for four additional five year periods in accordance with the terms of the ADT Wyoming Lease Agreement.”

Star Equity Holdings, Inc. entered into Purchase and Sale Agreement with Custom Capital Strategies, Inc. valued at $1.7 million (effective 2025-12-16).

“On December 16, 2025, Alliance Drilling Tools, LLC (“ADT”), a wholly owned subsidiary of Star Equity Holdings, Inc. (the “Company”), entered into a Purchase and Sale Agreement (the “ADT Wyoming PSA”) with Custom Capital Strategies, Inc. (“Custom Capital”), pursuant to which the parties agreed to consummate a sale and leaseback of the property located at 101-107 Pasture Drive, Evanston, Wyoming (the “ADT Wyoming Property”), for a total purchase price of $1.7 million, subject to adjustment for taxes and other charges and assessments (the “ADT Wyoming Sale and Leaseback Transaction”).”

Ultra Clean Holdings, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $600,000,000 principal amount (effective 2026-03-03).

“On March 3, 2026, Ultra Clean Holdings, Inc. (the “ Company ”) issued $600,000,000 principal amount of its 0.00% Convertible Senior Notes due 2031 (the “ Notes ”). The Notes were issued pursuant to, and are governed by, an indenture (the “ Indenture ”), dated as of March 3, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”).”

Leidos Holdings, Inc. entered into October 2020 Indenture with Citibank, N.A. valued at $600 million aggregate principal amount of 4.100% senior notes due 2029 and $800 million aggregate p (effective 2026-03-02).

“On March 2, 2026, Leidos, Inc. (the “ Issuer ”), a direct wholly-owned subsidiary of Leidos Holdings, Inc. (“ Leidos ”), issued and sold $600 million aggregate principal amount of 4.100% senior notes due 2029 (the “ 2029 Notes ”) and $800 million aggregate principal amount of 5.000% senior notes due 2036 (the “ 2036 Notes ” and, collectively with the 2029 Notes, the “ Notes ” and, such offering, the “ Notes Offering ”).”

Transglobal Management Group, Inc. entered into Standby Equity Commitment Agreement with MacRab LLC valued at up to $5,000,000 (effective 2026-02-17).

“On February 17, 2026, Transglobal Management Group, Inc. (the “Company”) entered into a Standby Equity Commitment Agreement (the “Equity Financing Agreement”) with MacRab LLC (the “Investor”).”

Esperion Therapeutics, Inc. entered into Agreement and Plan of Merger with Corstasis Therapeutics Inc., a Delaware corporation (“Corstasis”), and Cirrus Transaction Subsidiary, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”) valued at $75,000,000 (effective 2026-03-02).

“On March 2, 2026, Esperion Therapeutics, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Corstasis Therapeutics Inc., a Delaware corporation (“Corstasis”), and Cirrus Transaction Subsidiary, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”).”

Arbutus Biopharma Corp entered into Settlement Agreement with Moderna, Inc. and ModernaTx, Inc. (together, Moderna) valued at $950.0 million noncontingent lump sum payment (effective 2026-03-03).

“On March 3, 2026 (the “Effective Date”), Arbutus Biopharma Corporation (“Arbutus” or the “Company”), Genevant Sciences GmbH (“Genevant” and together with Arbutus, “Arbutus/Genevant”), and, solely for certain purposes, Genevant Sciences Ltd., and Moderna, Inc. and ModernaTx, Inc. (together, “Moderna”) entered into a settlement agreement (the “Settlement Agreement”) to resolve all patent infringement litigation between Arbutus/Genevant and Moderna pending in the U.S. and internationally relating to Moderna’s unauthorized use of Arbutus/Genevant’s lipid nanoparticle (“LNP”) delivery technology in its vaccines, including Spikevax® (the “LNP Litigation”).”

BRC Group Holdings, Inc. terminated Axos Guaranty with Axos Bank (effective 2026-02-25).

“On February 25, 2026, the guaranty dated January 18, 2024 (the “ Axos Guaranty ”) by BRC Group Holdings, Inc. (f/k/a B. Riley Financial, Inc.) (the “ Company ”) in favor of Axos Bank, as administrative agent (the “ Agent ”), and the secured parties under that certain Credit Agreement, dated as of January 18, 2024 (as amended, the “ B&W Axos Credit Agreement ”), among Babcock & Wilcox Enterprises, Inc. (“ B&W ”), the guarantors party thereto, the lenders party thereto, and the Agent, was terminated and is of no further force and effect.”

SRx Health Solutions, Inc. entered into Waiver with certain Existing Investors.

“certain Existing Investors have each entered into a limited waiver and consent agreement with the Company (each, a “Waiver”)”

SRx Health Solutions, Inc. entered into New Securities Purchase Agreement with certain accredited investors.

“The Company desires to enter into a securities purchase agreement (the “New Securities Purchase Agreement”) with certain accredited investors (the “New Buyers”)”

Karyopharm Therapeutics Inc. amended Second Amendment to Credit and Guaranty Agreement with Wilmington Savings Fund Society, FSB, as administrative agent and collateral agent (effective 2026-02-27).

“On February 27, 2026, Karyopharm Therapeutics Inc. (the “Company”) entered into the Second Amendment to Credit and Guaranty Agreement (the “Amendment”) with the lenders party thereto and Wilmington Savings Fund Society, FSB, as administrative agent and collateral agent”

Arq, Inc. amended Fourth Amendment with MidCap Funding IV Trust (effective 2026-02-27).

“On February 27, 2026 , Arq, Inc. (the "Company") and certain of its subsidiaries, entered into the fourth amendment (the "Fourth Amendment") to the Credit, Security and Guaranty Agreement (the "Revolving Credit Agreement"), dated December 27, 2024, as amended on May 6, 2025, December 9, 2025, and January 28, 2026, with MidCap Funding IV Trust, in its capacity as agent, the lenders from time to time party thereto, and any entities that become party thereto as Guarantors.”

Chiron Real Estate Inc. entered into Master Note and Guaranty Agreement with NYL Investors LLC and certain affiliates valued at $150.0 million (effective 2026-03-02).

“On March 2, 2026, Chiron Real Estate LP (the “Operating Partnership”), as issuer, and Chiron Real Estate Inc., as a guarantor, entered into a Master Note and Guaranty Agreement (the “Agreement”) with NYL Investors LLC (“New York Life”) and certain affiliates of New York Life (collectively, the “Purchasers”).”

Evolus, Inc. entered into Loan Agreement with Eclipse Business Capital LLC, as administrative agent, and the lenders party thereto valued at up to $30.0 million (effective 2026-03-03).

“On March 3, 2026, Evolus, Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan Agreement”) with Eclipse Business Capital LLC, as administrative agent (the “Agent”) and the lenders party thereto.”

Hepion Pharmaceuticals, Inc. entered into intellectual property license agreement with Cirna Diagnostics, LLC valued at upfront payment of $50,000 as well as certain patent expenses, up to $2,350,000 in milestone payment (effective 2026-02-25).

“On February 25, 2026, Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), entered into an intellectual property license agreement with Cirna Diagnostics, LLC (“ Cirna ”) pursuant to which the Company licensed certain liver disease diagnostic assets from Cirna.”

Knightscope, Inc. entered into Purchase Agreement with Event Risk LLC and Eric Rose (effective 2026-02-27).

“On February 27, 2026 (the "Closing Date"), Knightscope, Inc., a Delaware corporation (the "Company" or "Knightscope"), entered into a Securities Purchase Agreement (the "Purchase Agreement") with Event Risk LLC, an Indiana limited liability company ("Event Risk"), and Eric Rose (the "Seller"), pursuant to which Knightscope acquired all of the issued and outstanding membership interests of Event Risk (the "Acquired Interests").”

Babcock & Wilcox Enterprises, Inc. amended Tenth Amendment to Credit Agreement and Amendment to Security Agreement with Axos Bank valued at Amendment to Credit Agreement to increase borrowing availability based on inventory and receivables, (effective 2026-02-25).

“On February 25, 2026, Babcock & Wilcox Enterprises, Inc. (the “Company”) with certain subsidiaries of the Company as guarantors, BRC Group Holdings, Inc. (formerly known as B. Riley Financial, Inc.) (“BRC”), the lenders party to the Credit Agreement (as defined below), and Axos Bank (“Axos”), as administrative agent, entered into the Tenth Amendment to Credit Agreement and Amendment to Security Agreement (the “Tenth Amendment”), to that certain Credit Agreement, dated as of January 18, 2024 (as amended, restated, modified, or supplemented from time to time, the “Credit Agreement”).”

Roivant Sciences Ltd. entered into Settlement Agreement with Moderna, Inc. and ModernaTx, Inc. valued at $950.0 million noncontingent lump sum payment (effective 2026-03-03).

“On March 3, 2026 (the “Effective Date”), Genevant Sciences GmbH (“Genevant”), a subsidiary of Roivant Sciences Ltd. (the “Company” or “Roivant”), Arbutus Biopharma Corp. (together with Genevant, “Genevant/Arbutus”), and, solely for certain purposes, Genevant Sciences Ltd., and Moderna, Inc. and ModernaTx, Inc. (together, “Moderna”) entered into a settlement agreement (the “Settlement Agreement”)”

Vertiv Holdings Co entered into New Revolving Credit Facility with JPMorgan Chase Bank, N.A., as administrative agent valued at $2,500,000,000 (effective 2026-03-03).

“On March 3, 2026 (the “Closing Date”), the Company, as borrower, entered into a credit agreement (the “New Revolving Credit Facility”), with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.”

Vertiv Holdings Co terminated Term Loan Credit Agreement with Vertiv Group Corporation, as borrower, the guarantors party thereto, the lenders party thereto, and Citibank, N.A., as administrative agent and collateral agent (effective 2026-03-03).

“Upon such repayment, all commitments under the Term Loan Credit Agreement were terminated and all guarantees and liens securing obligations under the Term Loan Credit Agreement were released.”

Vertiv Holdings Co entered into Indenture with U.S. Bank Trust Company, National Association valued at $600,000,000 aggregate principal amount of its 4.850% Senior Notes due 2036, $500,000,000 aggregate (effective 2026-03-03).

“On March 3, 2026, Vertiv Holdings Co (the “Company”) completed an underwritten public offering (the “Offering”) of $600,000,000 aggregate principal amount of its 4.850% Senior Notes due 2036 (the “2036 Notes”), $500,000,000 aggregate principal amount of its 5.650% Senior Notes due 2046 (the “2046 Notes”), $500,000,000 aggregate principal amount of its 5.800% Senior Notes due 2056 (the “2056 Notes”), and $500,000,000 aggregate principal amount of its 5.950% Senior Notes due 2066 (the “2066 Notes” and, together with the 2036 Notes, the 2046 Notes and the 2056 Notes, the “Notes”).”

BuzzFeed, Inc. amended Second Consent Letter with the Lenders and Sound Point Agency LLC, as agent valued at $5.0 million (effective 2026-02-27).

“On February 27, 2026, the Lenders and the Agent consented to further amend Section 2.05(b)(iii) of the Credit Agreement, by deleting “February 27, 2026” (as previously amended) as the due date of the repayment of the $5.0 million of principal and inserting instead “March 6, 2026” (the “Second Consent Letter”).”

PMGC Holdings Inc. entered into Secured Pre-Paid Purchase #4 with an investor valued at $8,147,569.50 principal amount, $7,455,000 purchase price (effective 2026-02-06).

“On February 6, 2026 (“Effective Date”), the Company and an investor (“Investor”) consummated Secured Pre-Paid Purchase #4 (the “Fourth Pre-Paid Purchase”) under the previously disclosed equity purchase facility in the Company’s Current Report on Form 8-K filed with the U.S. Securities Exchange Commission (the “SEC”) on September 29, 2025, established pursuant to that certain Securities Purchase Agreement between the Company and the Investor dated September 23, 2025 (“Purchase Agreement”).”

Canton Strategic Holdings, Inc. amended Sales Agreement with Clear Street LLC and Virtu Americas LLC valued at $300,000,000 (effective 2026-03-03).

“On March 3, 2026, Canton Strategic Holdings, Inc. (the " Company "), entered into an amended and restated sales agreement (the " Sales Agreement ") with Clear Street LLC (" Clear Street ") and Virtu Americas LLC (" Virtu ", and together with Clear Street, the " Sales Agents "), relating to the sale of shares of the Company’s common stock”

Valuence Merger Corp. I entered into Note with VMCA Sponsor, LLC valued at $1,500,000 (effective 2026-02-27).

“On February 27, 2026, Valuence Merger Corp. I (the “Company”) issued a convertible promissory note to VMCA Sponsor, LLC, the Company’s sponsor (“Sponsor”), in the principal amount of $1,500,000 (the “Note”).”

GAXOS.AI INC. entered into Membership Interest Purchase Agreement with America First Defense.AI LLC valued at purchase of 19.99% membership interests for $2,900,000 (effective 2026-03-02).

“On March 2, 2026, Gaxos.ai Inc. (the "Company") entered into a Membership Interest Purchase Agreement (the "Purchase Agreement") with America First Defense.AI LLC, a New Mexico limited liability company ("AFD"), pursuant to which the Company agreed to purchase, and AFD agreed to sell, 19.99% of AFD's outstanding membership interests (the "Membership Interests") for an aggregate purchase price of $2,900,000.”

NEONC TECHNOLOGIES HOLDINGS, INC. entered into Securities Purchase Agreement with four investors (effective 2026-02-24).

“On February 24, 2026, the Company entered into another Securities Purchase Agreement to issue and sell up to the remaining 746,973 Shares”

Flowco Holdings Inc. entered into Registration Rights Agreement.

“On the Closing Date, the Company entered into a registration rights and lock-up agreement (the “Registration Rights Agreement”) with the Seller relating to the registered resale of the Stock Consideration.”

APEX Tech Acquisition Inc. entered into Private Placement Unit Purchase Agreement with APEX Innovation Acquisition Inc. (Sponsor) valued at purchase of units in private placement (effective 2025-08-07).

“A Private Placement Unit Purchase Agreement dated August 7, 2025, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.”

APEX Tech Acquisition Inc. entered into Registration Rights Agreement with APEX Innovation Acquisition Inc. and officers/directors valued at registration rights for shares (effective 2026-02-25).

“A Registration Rights Agreement dated February 25, 2026, by and among the Company, the Sponsor, and each of the officers and directors of the Company, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.”

APEX Tech Acquisition Inc. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at trust agreement for IPO proceeds (effective 2026-02-25).

“An Investment Management Trust Agreement dated February 25, 2026, by and between the Company and Continental, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

APEX Tech Acquisition Inc. entered into Letter Agreement with APEX Innovation Acquisition Inc. (Sponsor) valued at letter agreement among Company, officers, directors and Sponsor (effective 2026-02-25).

“A Letter Agreement dated February 25, 2026, (the “Letter Agreement”), by and among the Company, its officers, directors and the Company’s sponsor, APEX Innovation Acquisition Inc. (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.”

APEX Tech Acquisition Inc. entered into Rights Agreement with Continental Stock Transfer & Trust Company valued at rights to receive one-fourth of one Ordinary Share per Unit (effective 2026-02-25).

“A Rights Agreement dated February 25, 2026, by and between the Company and Continental Stock Transfer & Trust Company (“Continental”), as rights agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.”

APEX Tech Acquisition Inc. entered into Underwriting Agreement with A.G.P./Alliance Global Partners valued at gross proceeds $111,971,310 from IPO (effective 2026-02-25).

“An Underwriting Agreement dated February 25, 2026, by and between the Company and A.G.P./Alliance Global Partners, as representative of the underwriters (the “Representative”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.”

JACOBS SOLUTIONS INC. entered into Third Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $800,000,000 aggregate principal amount of its 4.750% Senior Notes due 2031 and $500,000,000 aggrega (effective 2026-03-03).

“On March 3, 2026, Jacobs Solutions Inc. (the “Company”) completed the previously announced offering (the “Offering”) of $800,000,000 aggregate principal amount of its 4.750% Senior Notes due 2031 (the “2031 Notes”) and $500,000,000 aggregate principal amount of its 5.375% Senior Notes due 2036 (the “2036 Notes””

MOOG INC. amended Eighth Amended and Restated Loan Agreement with HSBC Bank USA, National Association as Administrative Agent for the Lenders (effective 2026-02-26).

“On February 26, 2026, Moog Inc. (the “Company”) entered into the Eighth Amended and Restated Loan Agreement (the “Agreement”) by and among the Company, the lenders party thereto (the “Lenders”) and HSBC Bank USA, National Association as Administrative Agent for the Lenders.”

Covista Inc. terminated Indenture with U.S. Bank National Association, as trustee and notes collateral agent valued at approximately $404,950,000 (effective 2026-03-02).

“Upon deposit of the Redemption Payment with the Trustee on the Redemption Date, the Indenture was fully satisfied and discharged in accordance with its terms and the Company and the subsidiary guarantors party thereto have no further obligations under the Indenture.”

Covista Inc. amended Amendment No. 5 to Credit Agreement and Incremental Assumption Agreement with Morgan Stanley Senior Funding, Inc., as administrative agent, and the lender party valued at $510 million (effective 2026-03-02).

“On March 2, 2026, Covista Inc. (formerly known as Adtalem Global Education Inc.) ("Covista", the "Company", or "we") entered into Amendment No. 5 to Credit Agreement and Incremental Assumption Agreement, dated as of March 2, 2026 (the "Amendment"), by and among the Company, as borrower, the guarantors party thereto, the lender party thereto and Morgan Stanley Senior Funding, Inc. ("MSSF"), as administrative agent”

RLI CORP entered into Amended and Restated Credit Agreement with PNC Bank, National Association valued at $150 million aggregate commitment, increased from prior (effective 2026-02-26).

“On February 26, 2026, the Company entered into an amended and restated credit agreement (the “A&R Credit Agreement”) between the Company and PNC Bank, National Association.”